B arrett's esophagus (BE), a common condition, is the only known precursor to esophageal
adenocarcinoma (EAC). There is uncertainty about the best way to manage BE as most …

Survival rates for upper gastrointestinal cancers are poor and oesophageal cancer
incidence is increasing. Upper gastrointestinal cancer is also often missed during …

Barrett's esophagus (BE) is among the most common conditions encountered by the
gastroenterologist. In this document, the American College of Gastroenterology updates its …

Background This is a consensus developed by a group of expert endoscopists aiming to
standardise the preparation, process and endoscopic procedural steps for diagnosis of early …

Barrett's esophagus (BE) is characterized by a change of the normal stratified squamous
epithelium lining the esophagus to a metaplastic columnar epithelium with goblet cells. The …

Esophagogastroduodenoscopy (EGD) screening is being implemented in countries with a
high incidence of upper gastrointestinal (UGI) cancer. High‐quality EGD screening ensures …

Background Radiofrequency ablation (RFA) is a safe and effective treatment for Barrett's
esophagus (BE) that results in high rates of complete eradication of intestinal metaplasia …

Background Early cancer (high-grade dysplasia [HGD] and intramucosal carcinoma [ImCa])
associated with Barrett's esophagus (BE) may have a circumferential spatial predilection …

Barrett's esophagus (BE) is a premalignant condition characterized by the replacement of
the normal esophageal squamous epithelium with metaplastic intestinaltype columnar …

Background and Aims Complete endoscopic resection (CER) of Barrett's esophagus (BE)
with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EEA) is a …